United Therapeutics Acquires Pfizer Royalty Interest Tied to Ralinepag
Photo: TokenPost
United Therapeutics acquired Pfizer’s royalty interest linked to ralinepag, an experimental lung disease therapy, as it disclosed the deal alongside its third-quarter 2026 results Wednesday. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
